Hb Harrow [beta118(GH1)Phe-->Cys]: a new neutral hemoglobin variant.
Henthorn
J S
JS
Department of Haematology, Central Middlesex Hospital, London, UK.
Wajcman
H
H
Promé
D
D
Riou
J
J
Kister
J
J
Baudin-Creuza
V
V
Davies
S C
SC
Galactéros
F
F
D000328:Adult; D003545:Cysteine; D019281:Dimerization; D004586:Electrophoresis; D004739:England / Q000453:epidemiology; D004912:Erythrocytes / Q000473:pathology; D005260:Female; D006403:Hematologic Tests; D006455:Hemoglobins, Abnormal / Q000737:chemistry* / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D007194:India / Q000208:ethnology; D007231:Infant, Newborn; D008297:Male; D013058:Mass Spectrometry; D008970:Molecular Weight; D015997:Neonatal Screening; D010100:Oxygen / Q000378:metabolism; D010375:Pedigree; D010649:Phenylalanine; D017354:Point Mutation
D006455:Hemoglobins, Abnormal; C401762:hemoglobin Harrow; D010649:Phenylalanine; D003545:Cysteine; D010100:Oxygen